These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34065416)

  • 21. Acute promyelocytic leukemia and differentiation therapy: molecular mechanisms of differentiation, retinoic acid resistance and novel treatments.
    Özpolat B
    Turk J Haematol; 2009 Jun; 26(2):47-61. PubMed ID: 27265273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZYH005, a novel DNA intercalator, overcomes all-trans retinoic acid resistance in acute promyelocytic leukemia.
    Tong Q; You H; Chen X; Wang K; Sun W; Pei Y; Zhao X; Yuan M; Zhu H; Luo Z; Zhang Y
    Nucleic Acids Res; 2018 Apr; 46(7):3284-3297. PubMed ID: 29554366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid.
    Yaguchi M; Miyazawa K; Katagiri T; Nishimaki J; Kizaki M; Tohyama K; Toyama K
    Leukemia; 1997 Jun; 11(6):779-87. PubMed ID: 9177427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
    Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway.
    Ma L; Chen L; Li H; Ge L; Wang S; Zhang Z; Huang H; Shi L; Li T; Gu H; Lyu J; He L
    J Leukoc Biol; 2020 Apr; 107(4):685-693. PubMed ID: 32125014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X
    Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXO3A as a key molecule for all-trans retinoic acid-induced granulocytic differentiation and apoptosis in acute promyelocytic leukemia.
    Sakoe Y; Sakoe K; Kirito K; Ozawa K; Komatsu N
    Blood; 2010 May; 115(18):3787-95. PubMed ID: 20215638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasm prepared from all-trans retinoic acid (ATRA)-treated human hematopoietic progenitor cells induces differentiation of both ATRA sensitive and ATRA resistant leukemia cells.
    Zhang H; Wang Z; Zhou J
    Biol Pharm Bull; 2004 Apr; 27(4):570-3. PubMed ID: 15056869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
    Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
    Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
    Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
    Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
    Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
    Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
    Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
    Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
    Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
    Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential.
    Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F
    Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of enzastaurin and ATRA exerts dose-dependent dual effects on ATRA-resistant acute promyelocytic leukemia cells.
    Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Li ZY; Cai X
    Am J Cancer Res; 2019; 9(5):906-926. PubMed ID: 31218101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of retinoid sensitivity by MDR1 ribozymes in retinoic acid-resistant myeloid leukemic cells.
    Matsushita H; Kizaki M; Kobayashi H; Ueno H; Muto A; Takayama N; Awaya N; Kinjo K; Hattori Y; Ikeda Y
    Blood; 1998 Apr; 91(7):2452-8. PubMed ID: 9516145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.